LDA-13396-93007
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 850 / AZ
- Registered
- 2021-10-14
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-21
Dose 1 — Pfizer-BioNTech
-
2021-10-14
Registered in v-safe
-
2021-10-14
Dose 2 — Pfizer-BioNTech
- 2021-10-14
-
2021-10-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-16
- 2021-10-17
- 2021-10-18
- 2021-10-19
- 2021-10-20
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-11-11
- 2021-11-19
- 2021-11-25
-
2022-01-13
Survey response — 3 months, dose 2MedDRA: Cough, Headache, Nasopharyngitis, Pyrexia — Feeling: GoodFree text: Cough, colds, fever, headachesMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-21 | Pfizer-BioNTech | No |
| 2 | 2021-10-14 | Pfizer-BioNTech | No |
Free text
Release 10 — 3 months, dose 2
Symptoms: Cough, colds, fever, headaches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release